These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28074003)

  • 21. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
    Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
    Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon cancer-associated DNA polymerase β variant induces genomic instability and cellular transformation.
    Nemec AA; Donigan KA; Murphy DL; Jaeger J; Sweasy JB
    J Biol Chem; 2012 Jul; 287(28):23840-9. PubMed ID: 22573322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translesion Synthesis DNA Polymerase Kappa Is Indispensable for DNA Repair Synthesis in Cisplatin Exposed Dorsal Root Ganglion Neurons.
    Zhuo M; Gorgun MF; Englander EW
    Mol Neurobiol; 2018 Mar; 55(3):2506-2515. PubMed ID: 28391554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.
    Wang M; Long K; Li E; Li L; Li B; Ci S; He L; Pan F; Hu Z; Guo Z
    Oncogene; 2020 Aug; 39(33):5507-5519. PubMed ID: 32641859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.
    Iwatsuki M; Mimori K; Yokobori T; Tanaka F; Tahara K; Inoue H; Baba H; Mori M
    J Surg Oncol; 2009 Sep; 100(3):261-6. PubMed ID: 19330779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
    Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
    DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation.
    Raaphorst GP; Cybulski SE; Sobol R; Ng CE
    Anticancer Res; 2001; 21(3B):2079-83. PubMed ID: 11497301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of response to radiation, hyperthermia and cisplatin in parental and polymerase beta knockout cells.
    Raaphorst GP; Ng CE; Yang DP
    Int J Hyperthermia; 2002; 18(1):33-9. PubMed ID: 11820466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair inhibitors: the next major step to improve cancer therapy.
    Barakat K; Gajewski M; Tuszynski JA
    Curr Top Med Chem; 2012; 12(12):1376-90. PubMed ID: 22794314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Knock down' of DNA polymerase beta by RNA interference: recapitulation of null phenotype.
    Polosina YY; Rosenquist TA; Grollman AP; Miller H
    DNA Repair (Amst); 2004 Nov; 3(11):1469-74. PubMed ID: 15380102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA polymerase beta is critical for genomic stability of sperm cells.
    Kidane D; Dalal S; Keh A; Liu Y; Zelterman D; Sweasy JB
    DNA Repair (Amst); 2011 Apr; 10(4):390-7. PubMed ID: 21333614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.
    Fink D; Zheng H; Nebel S; Norris PS; Aebi S; Lin TP; Nehmé A; Christen RD; Haas M; MacLeod CL; Howell SB
    Cancer Res; 1997 May; 57(10):1841-5. PubMed ID: 9157971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.
    Canitrot Y; Cazaux C; Fréchet M; Bouayadi K; Lesca C; Salles B; Hoffmann JS
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12586-90. PubMed ID: 9770529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
    Pan C; Jin L; Wang X; Li Y; Chun J; Boese AC; Li D; Kang HB; Zhang G; Zhou L; Chen GZ; Saba NF; Shin DM; Magliocca KR; Owonikoko TK; Mao H; Lonial S; Kang S
    J Clin Invest; 2019 May; 129(6):2431-2445. PubMed ID: 31081803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens.
    Cabelof DC; Guo Z; Raffoul JJ; Sobol RW; Wilson SH; Richardson A; Heydari AR
    Cancer Res; 2003 Sep; 63(18):5799-807. PubMed ID: 14522902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents.
    Bergoglio V; Canitrot Y; Hogarth L; Minto L; Howell SB; Cazaux C; Hoffmann JS
    Oncogene; 2001 Sep; 20(43):6181-7. PubMed ID: 11593426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
    Chen F; Qin X; Xu G; Gou S; Jin X
    Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.